These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 16807406

  • 1. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 2. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
    [Abstract] [Full Text] [Related]

  • 3. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 4. Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD).
    Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
    Life Sci; 2009 Jun 05; 84(23-24):853-6. PubMed ID: 19351540
    [Abstract] [Full Text] [Related]

  • 5. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
    Nephrol Dial Transplant; 2009 Apr 05; 24(4):1162-9. PubMed ID: 19015171
    [Abstract] [Full Text] [Related]

  • 6. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
    Chen Y, Xu X, Sheng M, Zhang X, Gu Q, Zheng Z.
    Exp Eye Res; 2009 Dec 05; 89(6):1028-34. PubMed ID: 19748504
    [Abstract] [Full Text] [Related]

  • 7. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW.
    Cardiovasc Drugs Ther; 2006 Aug 05; 20(4):281-94. PubMed ID: 16897158
    [Abstract] [Full Text] [Related]

  • 8. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E, Honda M, Tokuyama H, Yamamoto T, Kajiya F, Saruta T.
    Hypertens Res; 2005 Feb 05; 28(2):181-9. PubMed ID: 16025746
    [Abstract] [Full Text] [Related]

  • 9. Anti-hypertensive effects of shichimotsukokato in 5/6 nephrectomized Wistar rats mediated by the DDAH-ADMA-NO pathway.
    Bai F, Makino T, Ono T, Mizukami H.
    J Nat Med; 2012 Oct 05; 66(4):583-90. PubMed ID: 22350214
    [Abstract] [Full Text] [Related]

  • 10. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
    Minakuchi H, Wakino S, Hosoya K, Sueyasu K, Hasegawa K, Shinozuka K, Yoshifuji A, Futatsugi K, Komatsu M, Kanda T, Tokuyama H, Hayashi K, Itoh H.
    Nephrol Dial Transplant; 2016 Mar 05; 31(3):413-23. PubMed ID: 26516203
    [Abstract] [Full Text] [Related]

  • 11. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T.
    Metabolism; 2012 Apr 05; 61(4):482-90. PubMed ID: 22000584
    [Abstract] [Full Text] [Related]

  • 12. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A, Zhao Y, Warren JS.
    Nephrol Dial Transplant; 2008 May 05; 23(5):1513-20. PubMed ID: 18204093
    [Abstract] [Full Text] [Related]

  • 13. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Onozato ML, Tojo A, Leiper J, Fujita T, Palm F, Wilcox CS.
    Diabetes; 2008 Jan 05; 57(1):172-80. PubMed ID: 17909098
    [Abstract] [Full Text] [Related]

  • 14. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr 05; 161(2):152-6. PubMed ID: 22285683
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome.
    Kaida Y, Ueda S, Yamagishi S, Nakayama Y, Ando R, Iwatani R, Fukami K, Okuda S.
    Life Sci; 2012 Sep 24; 91(9-10):301-5. PubMed ID: 22749861
    [Abstract] [Full Text] [Related]

  • 16. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, Hasegawa K, Sugano N, Kimoto M, Saruta T, Hayashi K.
    J Am Soc Nephrol; 2007 Mar 24; 18(3):741-9. PubMed ID: 17267746
    [Abstract] [Full Text] [Related]

  • 17. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
    Wang Y, Zhang M, Liu Y, Liu Y, Chen M.
    Vascul Pharmacol; 2011 Mar 24; 54(1-2):36-43. PubMed ID: 21167314
    [Abstract] [Full Text] [Related]

  • 18. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
    Segarra G, Cortina B, Mauricio MD, Novella S, Lluch P, Navarrete-Navarro J, Noguera I, Medina P.
    World J Gastroenterol; 2016 Dec 28; 22(48):10545-10556. PubMed ID: 28082806
    [Abstract] [Full Text] [Related]

  • 19. Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats.
    Cao Y, Mu JJ, Fang Y, Yuan ZY, Liu FQ.
    Int J Mol Sci; 2013 Apr 12; 14(4):8062-72. PubMed ID: 23584024
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb 12; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.